Dr. Yelena Solomatina, a Russian nutrition expert, revealed the damage caused by eating fried potatoes to the brain.
The expert indicated in an interview with Sputnik Radio that excessive consumption of fried potatoes can negatively affect the body. Because it has a high glycemic index, that is, after eating it, the blood glucose level rises sharply. According to her, consuming it frequently can lead to poor blood circulation.
“The human body is made up of what it eats,” she says. “Yes, this is a cliche, but it is true. French fries, unlike boiled potatoes, have a high glycemic index. If a person always eats french fries, his blood sugar level will often rise. And "This causes the body to react with recurring inflammation. For example, the lining of blood vessels becomes covered with cholesterol, which leads to circulatory disturbances."
She continues, and as a result, blood flow to the brain can decrease.
“The brain begins to receive less oxygen and nutrients, and as a result many neurons ‘break down,’” she says.
The first bowel cancer vaccine may be available within two years
The first vaccine to treat bowel cancer may be available in just two years, potentially eliminating the need for surgery.
In a step that is the first of its kind in the world, doctors at the Royal Surrey NHS Foundation Trust are testing the vaccine on patients in the United Kingdom and Australia.
Scientists hope that the treatment, which is given in three doses two weeks apart, will train the immune system to fight cancer and reduce its size.
If successful, this treatment could eliminate the need for the current standard treatment, which is surgery to remove the tumor, while preventing any cancer from recurring in the future.
The vaccine was developed by Dr. Tony Dillon, Consultant Medical Oncologist at Royal Surrey, and Professor Tim Price from the University of Adelaide.
The vaccine, made by biotechnology company Imugene, targets a protein that causes a "break" in the immune system, essentially "activating" the body's immune response.
It will first be trialled on 44 patients in the second or third stage of the disease before the cancer has spread to other parts of the body, at ten sites in the United Kingdom and Australia.
Patients will be given an endoscopy along with a tissue sample test to see if they qualify. They will then undergo tests before being given the three injections, two weeks apart.
Additional testing will be done before they undergo surgery to remove any remaining cancer.
The trial is being managed by Cancer Research UK's Southampton Clinical Trials Unit, with sites in Royal Surrey and Manchester Christie.
If the vaccine is successful, researchers are confident that it can be licensed for use within two years, with further trials being conducted in stage IV patients and different types of cancer.
Tags:
health